US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long MRNA ETF

142.28

+11.829.06%

Volume:243.98K

Turnover:33.33M

Market Cap:36.99M

PE:- -

High:144.32

Open:123.76

Low:123.44

Close:130.46

52wk High:167.89

52wk Low:14.95

Shares:260.00K

Float Shares:260.00K

Volume Ratio:1.08

T/O Rate:93.84%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Novartis announces FDA approval of Rhapsido for symptomatic dermographism

Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/MRNX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MRNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long MRNA ETF","latestPrice":142.275,"timestamp":1791402868655,"preClose":130.46,"halted":0,"volume":243975,"delay":0,"changeRate":0.09056415759619804,"floatShares":260000,"shares":260000,"eps":0,"marketStatus":"Trading","change":11.815,"latestTime":"10-07 15:54:31 EDT","open":123.76,"high":144.32,"low":123.44,"amount":33331469.2605,"amplitude":0.160049,"askPrice":143.56,"askSize":2,"bidPrice":141.45,"bidSize":2,"shortable":0,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791403200000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":130.46,"sharesOutstanding":30000,"nav":154.43,"aum":40151800,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":123.25,"preClose":130.46,"latestTime":"09:28 EDT","volume":5033,"amount":631583.1172,"timestamp":1791379695229,"change":-7.21,"changeRate":-0.055266,"amplitude":0.03457},"postHourTrading":{"tag":"盘后","latestPrice":130.75,"preClose":130.46,"latestTime":"19:59 EDT","volume":4617,"amount":605111.7842,"timestamp":1791331144780,"change":0.29,"changeRate":0.002223,"amplitude":0.011038},"volumeRatio":1.082651,"impliedVol":1.6915,"impliedVolPercentile":0.9667},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","floatShares":260000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.082651,"shares":260000,"dividePrice":0,"high":144.32,"amplitude":0.160049,"preClose":130.46,"low":123.44,"week52Low":14.95,"pbRate":"--","week52High":167.8902,"institutionHeld":0,"latestPrice":142.275,"eps":0,"divideRate":0,"volume":243975,"delay":0,"ttmEps":0,"open":123.76,"prevYearClose":20.61,"prevWeekClose":135.75,"prevMonthClose":140.98,"prevQuarterClose":140.98,"fiveDayClose":140.98,"twentyDayClose":72.66,"sixtyDayClose":37.81},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MRNX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MRNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MRNX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MRNX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673011453","title":"Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011453","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011453?lang=en_us&edition=fundamental","pubTime":"2026-10-08 00:15","pubTimestamp":1791389721,"startTime":"0","endTime":"0","summary":"• Amgen rose due to positive analyst commentary and strong third-quarter financial forecasts.\n• Robust commercial execution and advancing clinical pipeline drove higher investor confidence.\n• Strong balance sheet and favorable technical indicators continue attracting institutional capital.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262204356-market-movers-amgn-20261007","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","IXJ","FTXH","LGHT","AMGN","MEDX","IBB","MEDI","LLYX","AGNG","LLYZ","MRNY","LU1323610961.USD","TBXU","BBH","IHE","PBE","MRNA","IYH","CURE","THNR","BIB","ELIS","LU0708995401.HKD","TMED","ILDR","LU1221951046.USD","PPH","GDOC","FHLC","LLY","VHT","PJP","LU2242646821.SGD","MRNX","ELIL","CANC","LLII","RXL","JNJ","OZEM","WDNA","JDOC","TRUH","XLV","GNOM","MHIP","IDNA","IBBQ","HRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673526011","title":"S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2673526011","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673526011?lang=en_us&edition=fundamental","pubTime":"2026-10-08 00:00","pubTimestamp":1791388809,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDTS&P 500.SPXTop PerformersPercent ChangeEli Lilly and CompanyLLY.N+3.9%ResMed Inc.RMD.N+3.6%Hewlett Packard Enterprise CompanyHPE.N+3.3%Rollins IncROL.N+3.2%Moderna, Inc.MRNA.OQ+3.2%Bottom PerformersPercent ChangeEMCOR Group, Inc.EME.N-6.3%Comfort Systems USA, Inc.FIX.N-6.3%Caterpillar IncCAT.N-5.9%Teradyne, Inc.TER.OQ-5.8%Allegion PLCALLE.N-5.7%As of 12:00 p.m., the S&P 500.SPXlost 27.60 points, or 0.35%, to 7,791.33 and had posted 8 new 52-week highs and 10 new lows.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nL8N45T1JP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU1127390331.HKD","LU1061106388.HKD","LU0061475181.USD","LLYZ","LU2108987350.USD","LU1064131342.USD","SPUU","LU2462591350.SGD","LU2543165471.USD","LU2471134952.CNY","BK4567","LU0708995401.HKD","LU0820561818.USD","BK4139","MADE","PJP","LU0097036916.USD","LU0289739699.SGD","IE0002141913.USD","LU0238689110.USD","LU0274383776.USD","SMAX","LU2089283258.USD","SG9999015986.USD","BK4597","IXJ","LU0323591593.USD","LU0321505868.SGD","LU2106854487.HKD","SGXZ31699556.SGD","LU2008162690.USD","IE00BJT1NW94.SGD","LU2602419157.SGD","SPYU","LU1267930730.SGD","LU1861558580.USD","LU2491050071.SGD","LU0094547139.USD","LU2357305700.SGD","LU0266013472.USD","LU2168563687.JPY","LU0203201768.USD","GPIX","LU2271345857.HKD","LU1642822529.SGD","JDOC","LU2111349929.HKD","IDNA","LU0823416689.USD","EXI","LU1551013425.SGD","DBSC","LU0868494708.USD","ITOT","LU0203347892.USD","LU0345770993.USD","IE00BJJMRY28.SGD","LU0348723411.USD","LU1988902786.USD","LU2491049909.HKD","ALLE","LU1868836914.USD","ELIS","LU2750360641.GBP","BK4548","TMED","IE00B2B36J28.USD","LU2756315318.SGD","PPH","LU2896262040.SGD","MMAX","IE00BN0W2W23.USD","FHLC","LU0321505439.SGD","IE00BFSS7M15.SGD","IVV","LU1815336760.USD","SGXZ99366536.SGD","LLII","SPLV","SPYV","LU1623119135.USD","LU2746668974.SGD","SPYQ","ROL","LU0251131958.USD","MRNY","SCHB","IE00BWXC8680.SGD","LU0882574055.USD","LU0203202063.USD","LU0198837287.USD","LU0787776722.HKD","LU1093756325.SGD","IE0001KFT4U8.USD","LU1280957306.USD","LU2023251221.USD","BMAY","DMAX","LU0225283273.USD","LU2237438978.USD","LU2237443622.USD","CANC","LU2089984988.USD","VEU","BK4147","RXL","LU0640476718.USD","BK4129","LU0868494617.USD","CATG","BK4082","LU0203345920.USD","LU2360106947.USD","SDS","LU0133085943.USD","SG9999001176.USD","LU0006061336.USD","LU1551013342.USD","SPHD","SGXZ57979304.SGD","LU2168564065.EUR","BK4533","ACWI","LU0109391861.USD","LU0471298777.SGD","SGXZ51526630.SGD","IE00B775H168.HKD","GNOM","MHIP","SGXZ81514606.USD","SG9999015978.USD","LU0689472784.USD","MEDI","SG9999014906.USD","IE0004445015.USD","LU1323610961.USD","RMD","LU2361045086.USD","RSPN","IE00BD6J9T35.USD","LU0820561909.HKD","IE00BMPRXR70.SGD","LU1057294990.SGD","LU0963586101.USD","UXI","LU0234572021.USD",".SPX","LLY","FIX","LU2237443895.HKD","LU2756315664.SGD","LU1868837300.USD","SG9999014914.USD","MRNX","LU0471298694.HKD","LU0786609619.USD","LU0823434740.USD","LU2213496289.HKD","XYLD","LU1035775433.USD","SPHQ","LU0444971666.USD","LU0882574139.USD","LU2750360997.AUD","GDOC","BK4599","LU2361044865.SGD","LU2023250330.USD","LU2471134523.USD","LU2028103732.USD","SG9999018857.SGD","LU1923622291.USD","IE00BN0W2V16.EUR","SPUS","LU0048573561.USD","SPGP","SH","ILDR","LU1868836591.USD","LU2746668461.USD","RSPU","SPXL","SG9999018865.SGD","BK4520","LU2112291526.USD","MOAT","RSHO","LU0417517546.SGD","ETFT","BK4543","SPXU","LU0225771236.USD","VOOG","LLYX","IE0009355771.USD","LU2168564222.USD","LU0742534661.SGD","VTI","SCHX","IE00BN29S564.USD","TRUI","SG9999017495.SGD","SPDN","LU2125909759.SGD","LU1720051108.HKD","LU0964807845.USD","IE00B5TLWC47.USD","LU1712237335.SGD","OZEM","LU2461242641.AUD","XDTE","SG9999001176.SGD","IE00BK4W5M84.HKD","IJH","LU1232071149.USD","LU2264538146.SGD","IE00BJJMRZ35.SGD","IE0004445239.USD","LU0109394709.USD","BK4501","SG9999013999.USD","LU0006306889.USD","MRNA","VV","IE0005OL40V9.USD","LU0058720904.USD","LU2491050154.USD","LU0079474960.USD","LU0823434583.USD","LU0114720955.EUR","LU0943347566.SGD","IE00BMPRXQ63.HKD","LU1983299246.USD","LU0320765992.SGD","LU2177674079.SGD","BK4551","IE00BSNM7G36.USD","LU0957808578.USD","LU1069344957.HKD","LU0353189680.USD","SPMO","MEDX","LU2087625088.SGD","LU1979441026.SGD","SG9999015952.SGD","LU2417539215.USD","IE0034235188.USD","LU0210536198.USD","LU1720051017.SGD","LU2552382132.HKD","TERG","CURE","IE00B1XK9C88.USD","LU0466842654.USD","LU1917777945.USD","LU1989771016.USD","LU0353189763.USD","LU0158827781.USD","BK4534","CAT","LU2265009873.SGD","IE00BKDWB100.SGD","BK4086","IVW","IE00BN0W2T93.GBP","LU0096364046.USD","LU2552382215.SGD","LU1548497426.USD","IE00BK4W5L77.USD","XLV","LU0256863902.USD","LU2471134796.USD","LU2237443465.HKD","LU0354030511.USD","LU1145028129.USD","BK4007","LU0385154629.USD","LU2125909916.SGD","LU0158827948.USD","IE00B4JS1V06.HKD","THNR","EPAI","LU0316494557.USD","LU0820562030.AUD","BK4585","ELIL","LU0432979614.USD","LU1861559042.SGD","EME","LU2552382058.USD","IE00BMPRXN33.USD","FTXH","LGHT","LU0054578231.USD","AGNG","HPEL","SPYH","IYH","TERC","IE00BJLML261.HKD","UPRO","LU2168564495.EUR","LU0354030438.USD","HVAC","LU0106261372.USD","SPY","LU2462157665.USD","LU1366192091.USD","SG9999015945.SGD","TER","SG9999014880.SGD","LU0345770308.USD","LU1629891620.HKD","LU0225284248.USD","IE00B1BXHZ80.USD","LU2236285917.USD","LU1868836757.USD","SFY","BK4516","LU1691799644.USD","SG9999014898.SGD","RSP","SPYM","LU0256863811.USD","XLG","LU0251142724.SGD","SPYD","LU0985481810.HKD","LU2237443978.SGD","LU2237443382.USD","BK4568","LU0053671581.USD","GB00BDT5M118.USD","IE00BJJMRX11.SGD","JEPI","GSLC","HWAY","LU2324357040.USD","LU2237443549.SGD","LU2023250504.SGD","HRTS","GASZ","LU2361044949.HKD","IE00B4R5TH58.HKD","RSPA","LU2456880835.USD","LU2211815571.USD","LU0456855351.SGD","AIRR","NOBL","LU2471134879.HKD","SPXS","LU0889565916.HKD","LU0683600562.USD","LU0306807586.USD","VHT","WDNA","BK4149","LU2063271972.USD","LU1093756168.USD","LU0320765059.SGD","VOO","SPYG","BK4120","IE00BFTCPJ56.SGD","LU2468319806.SGD","HPE","IHE","LU2168564149.EUR","HIBL","IJR","BK4532","LU0170899867.USD","VTV","TRUH","HIBS","LU0122379950.USD","LU0174119429.USD","IE00BKPKM429.USD","BK4515","LU1974910355.USD","BK4170","BK4504","VBK","LU1868837136.USD","LU2089284900.SGD","YSPY","LU0306806265.USD","BK4588","LU0672654240.SGD","LU1023059063.AUD","LU1814569148.SGD","TSPY","ALLW","IE00BFSS8Q28.SGD","IE00B7KXQ091.USD","IVE","LU1291159041.SGD","SSO","LU1804176565.USD","LU0942090050.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011517","title":"Novartis announces FDA approval of Rhapsido for symptomatic dermographism","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011517","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011517?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:50","pubTimestamp":1791388212,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced that the Food and Drug Administration approved Rhapsido as the first treatment for adults with symptomatic dermographism i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","BK4532","LFSC","IE0009355771.USD","NVS","PINK","IEIH","MEDI","GDOC","BBP","LU0208291251.USD","LU0211331839.USD","IE00B4R5TH58.HKD","RSPH","TBXU","IE00BJJMRZ35.SGD","IE0002141913.USD","IDNA","NVIB","XLVX","GNMX","IE00B2B36J28.USD","MEDX","BMED","SYNB","PPH","LABU","TECB","IE00BJT1NW94.SGD","BK4585","BK4007","IYH","IBB","MRNY","IE00BFTCPJ56.SGD","MRNX","LU0320765489.SGD","LU0070302665.USD","PSCH","BK4588","BK4578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673118620","title":"Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673118620","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673118620?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:45","pubTimestamp":1791387900,"startTime":"0","endTime":"0","summary":"In Phase III RemIND trial, twice as many adults taking Rhapsido achieved complete hive resolution by Week 12 vs placebo, with responses seen by Week 21SD is most prevalent type of chronic inducible ur","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/07/3376686/0/en/novartis-rhapsido-remibrutinib-receives-fda-approval-as-first-treatment-for-symptomatic-dermographism-sd-expanding-its-use-beyond-chronic-spontaneous-urticaria-csu.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU1989772840.SGD","MEDI","XLVX","LABU","LU0267386448.USD","TECB","KBWB","LU0390134368.USD","RSPH","PSCH","BBP","LU1720051017.SGD","LFSC","IE00BZ1G4Q59.USD","LU1064131342.USD","SYNB","LU1668664300.SGD","LU1244550221.USD","IEIH","LU2487616109.SGD","LU2264538146.SGD","MRNY","IYH","GNMX","BK4581","IE00B3S45H60.SGD","LU1720051108.HKD","NVIB","IDNA","LU2357305700.SGD","LU2023251221.USD","BMED","LU1791710582.SGD","PINK","LU0912757837.SGD","LU0528227936.USD","GDOC","MRNX","SD","LU0106831901.USD","TBXU","LU2089284900.SGD","BK4585","IAI","BK4504","LU2028103732.USD","LU0795875169.SGD","LU0210528500.USD","FRTY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MRNX\",params:#limit:6,delay:false,,,undefined,":[]}}